Cowen Financial Products LLC - Jun 9, 2025 SCHEDULE 13G Report for UroGen Pharma Ltd. Ordinary Shares, par value NIS 0.01 per share (URGN)

Filing Manager: Cowen Financial Products LLC
Reporting Manager: Cowen Financial Products LLC
Security: UroGen Pharma Ltd. Ordinary Shares, par value NIS 0.01 per share
Symbol: URGN
Shares outstanding: 45.7M shares
Disclosed Ownership: 2.65M shares
Ownership: 5.8%
Form type: SCHEDULE 13G
Date filed: 6/13/2025, 11:38 AM
Date of event: Jun 9, 2025
Next filing: Jul 29, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Cowen Financial Products LLC	5.8%	2.65M	2.65M	0	John Holmes	John Holmes / Chief Operating Officer